BRAGGION, Marco
 Distribuzione geografica
Continente #
NA - Nord America 292
AS - Asia 48
EU - Europa 46
Totale 386
Nazione #
US - Stati Uniti d'America 291
CN - Cina 22
SG - Singapore 15
UA - Ucraina 15
DE - Germania 8
HK - Hong Kong 8
GB - Regno Unito 5
IT - Italia 5
FI - Finlandia 4
IE - Irlanda 4
RU - Federazione Russa 4
TR - Turchia 3
CA - Canada 1
SE - Svezia 1
Totale 386
Città #
Fairfield 56
Ashburn 30
Seattle 30
Houston 27
Woodbridge 23
Cambridge 19
Wilmington 18
Jacksonville 17
Singapore 15
Chandler 10
Hong Kong 8
New York 8
Princeton 8
Ann Arbor 7
Beijing 7
Nanjing 5
Dublin 4
Changsha 3
Des Moines 3
Helsinki 3
London 3
Moscow 3
San Diego 3
Boardman 2
Istanbul 2
Jinan 2
Brescia 1
Hangzhou 1
Islington 1
Lappeenranta 1
Ningbo 1
Rome 1
San Francisco 1
Shanghai 1
Shenyang 1
Taizhou 1
Toronto 1
Veneto 1
Totale 328
Nome #
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 129
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 114
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 104
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial 43
Totale 390
Categoria #
all - tutte 1.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 0 0 0 21 16 16 16 14 7 4
2020/202191 5 7 6 8 7 6 1 11 6 20 9 5
2021/202231 3 4 2 2 0 3 1 3 0 2 4 7
2022/202342 4 0 2 2 4 7 0 2 9 0 5 7
2023/202432 1 0 2 2 0 10 0 1 8 1 0 7
2024/202523 0 0 0 11 6 6 0 0 0 0 0 0
Totale 390